Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.77B | 19.54B | 19.01B | 17.77B | 7.61B | 3.82B |
Gross Profit | 12.46B | 5.59B | 5.96B | 3.03B | -198.60M | -1.51B |
EBITDA | 3.92B | 5.71B | 5.62B | 4.21B | 853.40M | -791.30M |
Net Income | 3.39B | 2.78B | 2.67B | 2.16B | -962.00M | -4.27B |
Balance Sheet | ||||||
Total Assets | 43.09B | 43.09B | 44.26B | 50.19B | 49.72B | 37.58B |
Cash, Cash Equivalents and Short-Term Investments | 8.78B | 8.78B | 12.66B | 16.73B | 14.17B | 8.05B |
Total Debt | 12.91B | 12.91B | 13.45B | 15.34B | 15.92B | 14.56B |
Total Liabilities | 27.02B | 27.02B | 27.52B | 29.94B | 26.92B | 21.30B |
Stockholders Equity | 15.66B | 15.66B | 16.34B | 19.86B | 22.41B | 15.91B |
Cash Flow | ||||||
Free Cash Flow | 2.94B | 2.83B | 3.73B | 7.47B | -289.20M | -6.21B |
Operating Cash Flow | 4.71B | 4.71B | 5.05B | 9.15B | 2.83B | -3.44B |
Investing Cash Flow | -3.30B | -3.30B | -1.44B | -490.10M | -2.32B | -1.40B |
Financing Cash Flow | -4.33B | -4.33B | -8.78B | -5.88B | 5.16B | 9.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $31.30B | 9.69 | 27.70% | ― | 4.23% | 13.13% | |
78 Outperform | $37.53B | 8.10 | 28.52% | 1.11% | 4.33% | -1.58% | |
75 Outperform | $30.74B | 14.28 | 27.12% | 1.65% | 10.61% | 37.32% | |
69 Neutral | $15.97B | 7.66 | 17.47% | 6.02% | 3.30% | 4.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $12.11B | 10.70 | 161.29% | 2.43% | 5.64% | 63.23% | |
58 Neutral | $7.60B | 14.81 | -21.27% | ― | 1.50% | ― |